v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue $ 139,544 $ 58,351 $ 252,628
Cost of goods sold 1,074,896 332,027 2,258,103 551,820
Gross loss (1,074,896) (192,483) (2,199,752) (299,192)
Operating expenses:        
Research and development 622,567 2,405,398 1,382,984 4,535,388
Sales and marketing 285,035 420,861 553,390 1,138,953
General and administrative 1,977,358 3,247,731 5,039,684 6,091,047
Total operating expenses 2,884,960 6,073,990 6,976,058 11,765,388
Loss from operations (3,959,856) (6,266,473) (9,175,810) (12,064,580)
Other income (expense):        
Interest income 140,567 117,278 293,865 261,638
Change in fair value - warrant liability 7,937,500 9,010,300
Change in fair value - derivative liability 2,618,000 2,627,000
Unrealized gain on marketable securities 301,921 146,935 266,902 198,215
Realized gain on marketable securities 74,998 8,193 452,121 73,193
Other income (expense), net (198,510) (9,166) (198,510) 52,532
Total other income (expense), net 10,874,476 263,240 12,451,678 585,578
Net income (loss) prior to provision for income taxes 6,914,620 (6,003,233) 3,275,868 (11,479,002)
Provision for income taxes
Net income (loss) 6,914,620 (6,003,233) 3,275,868 (11,479,002)
Dividends earned on H-7 convertible preferred stock (546,648) (998,734)
Accretion of discounts to redemption value of H-7 convertible preferred stock (1,999,136) (5,094,609)
Net income (loss) attributable to common stockholders $ 4,368,836 $ (6,003,233) $ (2,817,475) $ (11,479,002)
Net income (loss) per share, basic $ 0.78 $ (1.28) $ (0.53) $ (2.46)
Net income (loss) per share, diluted (NOTE 14) $ 0.14 $ (1.28) $ (0.53) $ (2.46)
Basic weighted average Common Stock outstanding 5,615,725 4,684,606 5,270,757 4,674,819
Diluted weighted average Common Stock outstanding (NOTE 14) 16,638,755 4,684,606 5,270,757 4,674,819

Source